Winners and losers
Despite the raft of new biotech company entries, the first quarter of 2022 has also seen massive job losses in the sector, particularly in the US. And the companies concerned are not just small startups, they include names in Big Pharma, like Pfizer, Lundbeck, Daiichi, Gilead and Biogen.